Table 2.
Variables | Mild group | Moderate group | Severe group |
---|---|---|---|
Number of patients | 25 | 21 | 19 |
Age (years) | 59.0 ± 18.4 | 53.2 ± 14.9 | 46.3 ± 13.0 b |
Gender (male: female) | 11:14 | 14:7 | 13:6 |
History of DM (years) | 7.62 ± 6.93 | 8.32 ± 5.93 | 4.77 ± 5.99 |
Hospital stay (days) | 9.89 ± 5.86 | 11.14 ± 4.86 | 13.00 ± 4.40 b |
Expenses (Yuan) | 9958.0 ± 7267.5 | 11,085.9 ± 7952.6 | 12,336.4 ± 8080.6 |
RBG (mmol/L) | 20.01 ± 5.32 | 20.45 ± 5.81 | 21.67 ± 7.20 |
HbA1c(%) | 11.63 ± 2.66 | 11.47 ± 2.65 | 11.69 ± 2.52 |
Fasting C-peptide (ng/mL) | 1.00 ± 0.89 | 0.39 ± 0.35 a | 0.32 ± 0.31bb |
Arterial PH | 7.30 ± 0.02 | 7.21 ± 0.05 aa | 7.11 ± 0.09 bb,cc |
SB (mmol/L) | 17.46 ± 2.23 | 12.37 ± 1.47 aa | 7.20 ± 2.15 bb,cc |
EPO (mOsm/L) | 307.20 ± 14.21 | 310.66 ± 16.65 | 319.03 ± 11.72 |
Na (mmol/L) | 135.84 ± 4.66 | 136.85 ± 6.08 | 135.05 ± 6.54 |
BUN (mmol/L) | 7.65 ± 6.15 | 8.29 ± 4.86 | 8.09 ± 4.44 |
Cr (umol/L) | 77.00 ± 25.05 | 102.52 ± 76.06 | 123.74 ± 83.72 b |
CRP (mg/L) | 10.50 (7.0–28.50) | 67.19 ± 52.06 | 91.60 ± 64.79 bb |
Note: mild group vs moderate group, a P < 0.05, aa P < 0.01
mild group vs severe group, b P < 0.05, bb P < 0.01
moderate group vs severe group, cc P < 0.01